4.8 Article

Mechanisms of nuclear content loading to exosomes

期刊

SCIENCE ADVANCES
卷 5, 期 11, 页码 -

出版社

AMER ASSOC ADVANCEMENT SCIENCE
DOI: 10.1126/sciadv.aax8849

关键词

-

资金

  1. NIH [P30 CA016672, UH3TR000943, P50 CA217685, P50 CA098258, R35 CA209904, 1S10OD012304-01]
  2. MD Anderson Cancer Center Ovarian Cancer Moon Shot Program
  3. Blanton-Davis Ovarian Cancer Research Program
  4. American Cancer Society Research Professor Award
  5. Judy's Mission
  6. Frank McGraw Memorial Chair in Cancer Research
  7. NCI Cancer Support Grant [P30CA16672]
  8. National Science Foundation [ACI-1548562]
  9. Cancer Prevention Research Institute of Texas (CPRIT) [RP130397]
  10. Mochida Memorial Foundation for Medical and Pharmaceutical Research
  11. Foundation for Women's Cancer (Clovis Oncology Post-Doctoral Fellowship Award)
  12. NIH Partnership for Excellence in Cancer Research [U54CA096300/U54CA096297]

向作者/读者索取更多资源

Exosome cargoes are highly varied and include proteins, small RNAs, and genomic DNA (gDNA). The presence of gDNA suggests that different intracellular compartments contribute to exosome loading, resulting in distinct exosome subpopulations. However, the loading of gDNA and other nuclear contents into exosomes (nExo) remains poorly understood. Here, we identify the relationship between cancer cell micronuclei (MN), which are markers of genomic instability, and nExo formation. Imaging flow cytometry analyses reveal that 10% of exosomes derived from cancer cells and <1% of exosomes derived from blood and ascites from patients with ovarian cancer carry nuclear contents. Treatment with genotoxic drugs resulted in increased MN and nExos both in vitro and in vivo. We observed that multivesicular body precursors and exosomal markers, such as the tetraspanins, directly interact with MN. Collectively, this work provides new insights related to nExos, which have implications for cancer biomarker development.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据